| Date Filed | Type | Description |
| 06/15/2023 |
4
| Patzer Eric (Executive Chairman) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options
@ $0.16, valued at
$4.8k
Exercised 12,000 restricted stock units
@ $0 |
|
| 06/15/2023 |
4
| HAMILTON JOHN F (Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options
@ $0.16, valued at
$2.4k
Exercised 5,000 restricted stock units
@ $0 |
|
| 06/15/2023 |
4
| Truong Vu (CEO and Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options
@ $0.16, valued at
$16k
Exercised 15,000 restricted stock units
@ $0 |
|
| 06/15/2023 |
4
| Windham-Bannister Susan Richards (Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options
@ $0.16, valued at
$2.4k
Exercised 5,000 restricted stock units
@ $0 |
|
| 06/15/2023 |
4
| Jafri Hasan (Chief Medical Officer) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options
@ $0.16, valued at
$4k
Exercised 10,000 restricted stock units
@ $0 |
|
| 06/15/2023 |
4
| KURLAND FRED (CFO) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options
@ $0.16, valued at
$1.6k
Exercised 4,000 restricted stock units
@ $0 |
|
| 12/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/07/2022 |
4
| Truong Vu (CEO) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 restricted stock units
@ $0 |
|
| 12/07/2022 |
4
| Patzer Eric (Executive Chairman) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 24,000 restricted stock units
@ $0 |
|
| 12/07/2022 |
4
| RUFFOLO ROBERT R (Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 restricted stock units
@ $0 |
|
| 12/07/2022 |
4
| Jafri Hasan (Chief Medical Officer) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 restricted stock units
@ $0 |
|
| 12/07/2022 |
4
| Gibbs Craig S (Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 restricted stock units
@ $0 |
|
| 12/07/2022 |
4
| KURLAND FRED (CFO) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 8,000 restricted stock units
@ $0 |
|
| 12/07/2022 |
4
| HAMILTON JOHN F (Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 restricted stock units
@ $0 |
|
| 12/07/2022 |
4
| Windham-Bannister Susan Richards (Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 restricted stock units
@ $0 |
|
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2021 |
4
| Windham-Bannister Susan Richards (Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 8,500 options
@ $3.6, valued at
$30.6k
|
|
| 10/05/2021 |
4
| RUFFOLO ROBERT R (Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 7,000 options
@ $3.6, valued at
$25.2k
|
|
| 10/05/2021 |
4
| KURLAND FRED (CFO) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options
@ $3.6, valued at
$72k
|
|
| 10/05/2021 |
4
| Jafri Hasan (Chief Medical Officer) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options
@ $3.6, valued at
$108k
|
|
| 10/05/2021 |
4
| HAMILTON JOHN F (Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 9,400 options
@ $3.6, valued at
$33.8k
|
|
| 10/05/2021 |
4
| Gibbs Craig S (Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 7,900 options
@ $3.6, valued at
$28.4k
|
|
| 09/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2021 |
4
| Truong Vu (CEO) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $5.11, valued at
$25.6k
|
|
| 07/27/2021 |
4
| Patzer Eric (Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Bought 5,175 shares
@ $4.84, valued at
$25k
|
|
| 05/13/2021 |
4
| Truong Vu (CEO and Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 53,340 options
@ $6.25, valued at
$333.4k
|
|
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/06/2020 |
4
| Truong Vu (CEO and Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Exercised 50,000 options
@ $5.24, valued at
$262k
|
|
|